[go: up one dir, main page]

GB201018325D0 - Treatment for dupuytren's disease - Google Patents

Treatment for dupuytren's disease

Info

Publication number
GB201018325D0
GB201018325D0 GBGB1018325.9A GB201018325A GB201018325D0 GB 201018325 D0 GB201018325 D0 GB 201018325D0 GB 201018325 A GB201018325 A GB 201018325A GB 201018325 D0 GB201018325 D0 GB 201018325D0
Authority
GB
United Kingdom
Prior art keywords
dupuytren
disease
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1018325.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Kennedy Institute of Rheumotology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kennedy Institute of Rheumotology filed Critical Kennedy Institute of Rheumotology
Priority to GBGB1018325.9A priority Critical patent/GB201018325D0/en
Publication of GB201018325D0 publication Critical patent/GB201018325D0/en
Priority to US13/882,262 priority patent/US9138458B2/en
Priority to RU2013123796/15A priority patent/RU2013123796A/en
Priority to JP2013535462A priority patent/JP6004494B2/en
Priority to DK11779628.4T priority patent/DK2632446T3/en
Priority to CA2847197A priority patent/CA2847197C/en
Priority to AU2011322482A priority patent/AU2011322482B2/en
Priority to EP11779628.4A priority patent/EP2632446B1/en
Priority to PCT/EP2011/069147 priority patent/WO2012056044A1/en
Priority to ES11779628T priority patent/ES2715204T3/en
Priority to US14/852,442 priority patent/US10273296B2/en
Priority to JP2016166524A priority patent/JP2017014266A/en
Priority to AU2017204267A priority patent/AU2017204267B2/en
Priority to US16/399,547 priority patent/US10669334B2/en
Ceased legal-status Critical Current

Links

GBGB1018325.9A 2010-10-30 2010-10-30 Treatment for dupuytren's disease Ceased GB201018325D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB1018325.9A GB201018325D0 (en) 2010-10-30 2010-10-30 Treatment for dupuytren's disease
ES11779628T ES2715204T3 (en) 2010-10-30 2011-10-31 Dupuytren's disease treatment
AU2011322482A AU2011322482B2 (en) 2010-10-30 2011-10-31 Treatment for Dupuytren's disease
PCT/EP2011/069147 WO2012056044A1 (en) 2010-10-30 2011-10-31 Treatment for dupuytren's disease
JP2013535462A JP6004494B2 (en) 2010-10-30 2011-10-31 Treatment of Dupuytren's disease
DK11779628.4T DK2632446T3 (en) 2010-10-30 2011-10-31 TREATMENT OF DUPUYTRY CONTRACT
CA2847197A CA2847197C (en) 2010-10-30 2011-10-31 Treatment for dupuytren's disease
US13/882,262 US9138458B2 (en) 2010-10-30 2011-10-31 Treatment for dupuytren's disease
EP11779628.4A EP2632446B1 (en) 2010-10-30 2011-10-31 Treatment for dupuytren's disease
RU2013123796/15A RU2013123796A (en) 2010-10-30 2011-10-31 METHOD FOR TREATING DUPUITREN'S DISEASE
US14/852,442 US10273296B2 (en) 2010-10-30 2015-09-11 Treatment for dupuytren's disease
JP2016166524A JP2017014266A (en) 2010-10-30 2016-08-29 Treatment for dupuytren's disease
AU2017204267A AU2017204267B2 (en) 2010-10-30 2017-06-23 Treatment for dupuytren's disease
US16/399,547 US10669334B2 (en) 2010-10-30 2019-04-30 Treatment for Dupuytren's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1018325.9A GB201018325D0 (en) 2010-10-30 2010-10-30 Treatment for dupuytren's disease

Publications (1)

Publication Number Publication Date
GB201018325D0 true GB201018325D0 (en) 2010-12-15

Family

ID=43401537

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1018325.9A Ceased GB201018325D0 (en) 2010-10-30 2010-10-30 Treatment for dupuytren's disease

Country Status (1)

Country Link
GB (1) GB201018325D0 (en)

Similar Documents

Publication Publication Date Title
IL217768A (en) Laquinimod for the treatment of crohn's disease
EP2621588A4 (en) Methods and compositions for disease treatment using inhalation
GB2465897B (en) Respiratory disease treatment
EP2707369A4 (en) Compositions and methods for treating alzheimer's disease
SG11201403272YA (en) Compositions and methods for treating alzheimer's disease
EP2485733A4 (en) Methods for treating alzheimer's disease
IL230441A0 (en) Diagnosis of alzheimer's disease
IL260078B (en) Therapy for use for the treatment of gaucher's disease
GB201002243D0 (en) Respiratory disease treatment
IL225755B (en) 6-amidoderivatives of 4,5a-epoxymorphinans for treatment of pain
GB201021397D0 (en) Diagnosis of Crohn's disease
GB201002224D0 (en) Respiratory disease treatment
EP2601954A4 (en) Therapeutic agent for disease
EP2410846A4 (en) Glycolipids as treatment for disease
ZA201402477B (en) Compounds for use in the treatment of alzheimer's disease
PL2565184T3 (en) Therapeutic agent and preventative agent for alzheimer's disease
GB201018325D0 (en) Treatment for dupuytren's disease
GB201018362D0 (en) Treatment of dupuytren's disease
GB201113718D0 (en) Treatment of Dupuytren's Disease
GB201009094D0 (en) Compounds for the treatment of closridium difficile-associated disease
GB201001903D0 (en) Respiratory disease treatment
GB201001893D0 (en) Respiratory disease treatment
GB201002235D0 (en) Respiratory disease treatment
GB201013810D0 (en) Huntington's disease
GB0901832D0 (en) Respiratory disease treatment

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: IMPERIAL INNOVATIONS LTD

Free format text: FORMER OWNER: IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE

AT Applications terminated before publication under section 16(1)